FDA Approves Filter To Prevent Recurrent Pulmonary Embolisms

June 8, 2009 by admin 

The Food and Drug Administration (FDA) have approved a device made by Vancouver based Angiotech to treat people with pulmonary artery blockages
The Food and Drug Administration (FDA) have approved a device made by Vancouver based Angiotech to treat people with pulmonary artery blockages.

Pulmonary embolisms are very, very serious and occur when part of a blood clot breaks away and travels via the blood stream throughout a person’s body.

“We are excited to commence commercial sales of Option through our dedicated interventional sales team in the very near future,” stated Angiotech president and CEO William Hunter.

The filter device is called Option Inferior Vena Cava Filter, which is implanted into the inferior vena cava to prevent the risk of recurring artery blockages.

When news of the FDA approval went public, shares of Angiotech jumped, opening at $3 on the Toronto stock exchange.

Comments are closed.